TNI BioTech and Hubei Qianjiang Pharmaceutical have entered into a partnership to develop new cancer therapeutics. The cancer drugs will be based on TNI BioTech's patents covering Methionine Enkephalin. TNI BioTech will carry out ...
Tags: Hubei Qianjiang Pharmaceutical, cancer drugs, methionine enkephalin
Apexigen, a biopharmaceutical company, has announced the filing of investigational new drug (IND) application for APX001, also known as SSS07, by its partner 3SBio [SSRX] of Shenyang, China. With the IND approval, APX001/SSS07 will be ...
Tags: IND approval, clinical trials, autoimmune diseases, inflammatory diseases
Shandong Taibang Biological Products has received approval from the China State Food and Drug Administration (SFDA) to begin trials for its human fibrinogen to be used to treat congenital fibrinogen deficiency and acquired fibrinogen ...
Tags: clinical trials, fibrinogen deficiency, pharmaceutical product